# PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer

> **NCT04560725** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 50 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 11C-Choline

## Key facts

- **NCT ID:** NCT04560725
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-10-22
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04560725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04560725, "PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04560725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*